Avinew Fizz effervescent tablet for chickens and turkeys
Avinew Fizz effervescent tablet for chickens and turkeys
Authorised
- Newcastle disease virus, strain VG/GA, Live
Product identification
Medicine name:
Avinew Fizz effervescent tablet for chickens and turkeys
Avinew Fizz comprimé effervescent pour poulets et dindes
Active substance:
- Newcastle disease virus, strain VG/GA, Live
Target species:
-
Chicken
-
Turkey
Route of administration:
-
Ocular use
-
Oculonasal use
-
Oral use
Product details
Active substance and strength:
-
Newcastle disease virus, strain VG/GA, Live5.50/unit(s)1.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
Ocular use
-
Chicken
-
Meat and offalno withdrawal periodZero days
-
-
-
Oculonasal use
-
Turkey
-
Meat and offalno withdrawal periodZero days
-
-
Chicken
-
Meat and offalno withdrawal periodZero days
-
-
-
Oral use
-
Chicken
-
Meat and offalno withdrawal periodZero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Carton box of 10 polyamide - aluminium - PVC / aluminium blister of 10 tablets of 2000 doses
- Carton box of 10 polyamide - aluminium - PVC / aluminium blister of 10 tablets of 1000 doses
- Carton box of 1 polyamide - aluminium - PVC / aluminium blister of 10 tablets of 2000 doses
- Carton box of 1 polyamide - aluminium - PVC / aluminium blister of 10 tablets of 1000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 344/07/12/2023
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0410/001
Concerned member states:
-
Belgium
-
Luxembourg
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 17/04/2025